BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 387233)

  • 1. Oral adjuvant therapy in breast carcinoma--a multicentre trial.
    Leiberman DP; Berstock DA; Houghton J; Kearney G
    Cancer Treat Rev; 1979 Jun; 6 Suppl():91-6. PubMed ID: 387233
    [No Abstract]   [Full Text] [Related]  

  • 2. Melphalan and methotrexate in advanced breast cancer.
    Priestman TJ; Salaman PF
    Cancer Treat Rep; 1978 Dec; 62(12):2111-2. PubMed ID: 751718
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy for early breast cancer.
    Smith IE
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):379-80. PubMed ID: 6409315
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
    Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
    Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
    [No Abstract]   [Full Text] [Related]  

  • 5. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
    Rivkin SE; Glucksberg H; Foulkes M
    Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicity of oral adjuvant chemotherapy in breast cancer.
    Murray JG; MacIntyre J; Leiberman DP; Leaper DJ
    Br Med J; 1978 Feb; 1(6110):408-9. PubMed ID: 624031
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized controlled trial of prophylactic cytotoxic chemotherapy in potentially curable breast cancer.
    Gough MH; Durrant KR; Giraud-Saunders AM; Paine CH; McPherson K; Vessey MP
    Br J Surg; 1985 Mar; 72(3):182-5. PubMed ID: 3884084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple trials of adjuvant chemohormonal therapy in the treatment of breast cancer: preliminary results--the ECOG experience.
    Carbone PP
    Breast Cancer Res Treat; 1983; 3 Suppl():S35-8. PubMed ID: 6367858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of systemic adjuvant therapy in the management of primary breast cancer.
    Fisher B; Wolmark N
    Surg Clin North Am; 1981 Dec; 61(6):1347-60. PubMed ID: 7031938
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancer.
    Perez DJ; Powles TJ; Gazet JC; Ford HT; Coombes RC
    Cancer Chemother Pharmacol; 1984; 13(1):36-8. PubMed ID: 6203662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma.
    Sulkes A; Brufman G; Rizel S; Weshler Z; Biran S; Fuks Z
    Int J Radiat Oncol Biol Phys; 1983 Jan; 9(1):17-21. PubMed ID: 6687724
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK
    Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract]   [Full Text] [Related]  

  • 16. Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
    Stephens EJ; Wood HF; Mason B
    Recent Results Cancer Res; 1978; 68():139-45. PubMed ID: 379932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy in curable breast cancer].
    Seradour B; Thomas M
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124
    [No Abstract]   [Full Text] [Related]  

  • 18. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
    Smith IE; Powles TJ
    Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in breast cancer--a multicenter trial.
    Faber P; Jesdinsky H
    Cancer Treat Rev; 1979 Jun; 6 Suppl():75-8. PubMed ID: 387230
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
    Wilcox PM; Fetting JH; Nettesheim KM; Abeloff MD
    Cancer Treat Rep; 1982 Aug; 66(8):1601-4. PubMed ID: 7049385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.